Tradestie Institutional Equity Comparison Engine
ABVC vs AQB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVC Overall Edge
ABVC Captures Institutional Edge (2โ1 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABVC BioPharma, Inc. Common Stock (ABVC) driven by superior Growth & Margin, Options & Structure while AQB counters with relative strength in Momentum & Technical. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus AQB at N/M Forward P/E and 0.0% operating margin (-93.5% YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AQB sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVC N/M vs AQB N/M Fwd P/E
Growth & Margin Winner
ABVC
Op Margin 0.0% vs 0.0% ยท YoY +104.5% vs -93.5%
Momentum & Technical Winner
AQB
1Y -67.8% vs -23.6% ยท 52W Pos 10% vs 11%
Options & Structure Winner
ABVC
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
ABVC
NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.94
+0.0% 1D
Market Cap
$24.8M
1M Return
+3.3%
1Y Return
-67.81%
Forward P/E
N/M
Unified AI Score
34.2 / 100
SELL
Tech 15.0
Fund 40.0
Flow 50.0
Mom 40.0
AQB
NASDAQ
AquaBounty Technologies, Inc.
Fishing, Hunting And Trapping
$0.82
+2.01% 1D
Market Cap
$9.7M
1M Return
-21.37%
1Y Return
-23.57%
Forward P/E
N/M
Unified AI Score
44.6 / 100
HOLD
Tech 33.0
Fund 49.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVC -67.81%
AQB -23.57%
Spread: +44.24 pp (AQB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVC TTM Op. Margin: 0.0%
AQB TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs AQB. Trailing 12-month operating profitability (ABVC 0.0% vs AQB 0.0%) and valuation multiples (ABVC N/M vs AQB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVC | AQB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $24.8M | $9.7M | Larger Scale | ABVC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +104.5% | -93.5% | Higher Growth | ABVC |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -52.7% | -68.9% | Higher ROE | ABVC |
| 52-Week Range Position Momentum | 10% ($1โ$3) | 11% ($1โ$2) | Stronger Trend | AQB |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 53% Vol | 0.93ฮฒ ยท 117% Vol | Lower Realized Risk | ABVC |
| Unified Institutional Score Composite Signal | 34.2 / 100 (SELL) | 44.6 / 100 (HOLD) | Higher Composite | AQB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVC vs AQB Buy Guide
ABVC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AQB
BREAKDOWN
69d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVC nor AQB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.